QUEBEC CITY, Oct. 27, 2015 /CNW Telbec/ - Aeterna Zentaris
Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced
that Institutional Shareholder Services Inc. (ISS) and Glass Lewis
& Co., two leading independent proxy research and advisory
firms, have published reports recommending that the Company's
shareholders vote FOR a special resolution authorizing the
consolidation of the issued and outstanding common shares of the
Company at a consolidation ratio of between 8-for-1 and 100-for-1
(the "Share Consolidation") at a special meeting of shareholders to
be held on Monday, November 16, 2015
at 9:30 a.m. (Eastern time) (the
"Meeting").
"I am pleased that ISS and Glass Lewis, two leading independent
research and advisory firms, validate the views of our Board of
Directors that the proposed share consolidation would be in the
best interest of the Company and its shareholders," stated
David A. Dodd, Chairman, President
and CEO of the Company. "We believe that the Share
Consolidation is necessary in order to avoid the delisting of our
Common Shares from The NASDAQ Capital Market and to improve our
capital structure", Mr. Dodd concluded.
The Management Information Circular (the "Circular") sent to
shareholders contains, among other things, details concerning the
Share Consolidation, reasons that the Company's Board of Directors
recommends the Share Consolidation, requirements for the Share
Consolidation to be implemented and the procedure for receiving new
shares if the Share Consolidation is implemented, as well as the
procedures for voting at the meeting and other related matters.
Shareholders are urged to carefully review the Circular and
accompanying materials as they contain important information
regarding the Share Consolidation and its consequences to
Shareholders. A copy of the Circular is available on SEDAR at
www.sedar.com and on the EDGAR section of the U.S. Securities and
Exchange Commission's website at www.sec.gov.
The Board of Directors UNANIMOUSLY recommends
that Shareholders vote FOR the Share Consolidation.
YOUR VOTE IS IMPORTANT. VOTE
TODAY!
A proxy form or voting instruction form will accompany the
Meeting materials you receive by mail. Instructions on how to vote,
which vary depending on whether you are a registered or beneficial
shareholder of the Company are provided in the Circular and the
proxy form or voting instruction form.
If you have any questions or require more information with
regard to the procedures for voting, please contact Laurel Hill
Advisory Group, the Company's proxy solicitation agent, toll free
at 1-877-452-7184, collect at 416-304-0211 or by email at
assistance@laurelhill.com.
About Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel treatments in
oncology, endocrinology and women's health. For more
information, visit www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.